Janux Therapeutics, Inc.
Total Trades
46
Buys
5
Sells
26
Largest Trade
N/A
Insiders
10
Institutional Funds
125
Inst. Value
$1M+
Activist Filings
42
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Meyer Andrew Hollman | Chief Business Off… | SELL | $15K–$50K | 2K | $13.73 | Jan 3, 2026 |
| DiRaimondo Thomas | Chief Scientific O… | SELL | $15K–$50K | 3K | $13.73 | Jan 3, 2026 |
| DiRaimondo Thomas | Chief Scientific O… | GRANT | N/A | 31K | — | Jan 3, 2026 |
| Campbell David Alan | President and CEO | GRANT | N/A | 97K | — | Jan 3, 2026 |
| Campbell David Alan | President and CEO | SELL | $100K–$500K | 8K | $13.73 | Jan 3, 2026 |
| Winter Charles M. | Chief Technical Of… | GRANT | N/A | 29K | — | Jan 3, 2026 |
| Winter Charles M. | Chief Technical Of… | SELL | $15K–$50K | 2K | $13.73 | Jan 3, 2026 |
| McIver Zachariah | Chief Medical Offi… | GRANT | N/A | 29K | — | Jan 3, 2026 |
| McIver Zachariah | Chief Medical Offi… | SELL | $15K–$50K | 3K | $13.73 | Jan 3, 2026 |
| Dobek Maria | Vice President | GRANT | N/A | 19K | — | Jan 3, 2026 |
| Dobek Maria | Vice President | SELL | $15K–$50K | 1K | $13.73 | Jan 3, 2026 |
| Meyer Andrew Hollman | Chief Business Off… | SELL | $100K–$500K | 3K | $32.98 | Dec 4, 2025 |
| Meyer Andrew Hollman | Chief Business Off… | EXERCISE | $15K–$50K | 3K | $10.59 | Dec 4, 2025 |
| Meyer Andrew Hollman | Chief Business Off… | SELL | $50K–$100K | 3K | $30.00 | Nov 15, 2025 |
| Meyer Andrew Hollman | Chief Business Off… | EXERCISE | $15K–$50K | 3K | $10.59 | Nov 15, 2025 |
| Meyer Andrew Hollman | Chief Business Off… | SELL | $500K+ | 17K | $30.06 | Oct 31, 2025 |
| Meyer Andrew Hollman | Chief Business Off… | EXERCISE | $100K–$500K | 17K | $6.76 | Oct 31, 2025 |
| Meyer Andrew Hollman | Chief Business Off… | EXERCISE | $1K–$15K | 3K | $4.21 | May 3, 2025 |
| Meyer Andrew Hollman | Chief Business Off… | SELL | $100K–$500K | 3K | $32.03 | May 3, 2025 |
| Meyer Andrew Hollman | Chief Business Off… | EXERCISE | $1K–$15K | 3K | $4.21 | Apr 24, 2025 |
| Meyer Andrew Hollman | Chief Business Off… | SELL | $100K–$500K | 3K | $30.00 | Apr 24, 2025 |
| Campbell David Alan | President and CEO | SELL | $100K–$500K | 5K | $60.00 | Jan 9, 2025 |
| Meyer Andrew Hollman | Chief Business Off… | GRANT | N/A | 18K | — | Jan 3, 2025 |
| Meyer Andrew Hollman | Chief Business Off… | SELL | $500K+ | 13K | $54.88 | Jan 3, 2025 |
| Campbell David Alan | President and CEO | SELL | $1M+ | 25K | $56.19 | Dec 28, 2024 |
| Campbell David Alan | President and CEO | SELL | $1M+ | 15K | $67.00 | Dec 4, 2024 |
| Campbell David Alan | President and CEO | SELL | $1M+ | 25K | $51.60 | Nov 28, 2024 |
| Campbell David Alan | President and CEO | SELL | $1M+ | 25K | $53.54 | Oct 30, 2024 |
| Lichter Jay | 10% Owner | EXERCISE | $50K–$100K | 4K | $17.29 | Oct 24, 2024 |
| Lichter Jay | 10% Owner | SELL | $100K–$500K | 4K | $46.68 | Oct 24, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $1M+ | 1.2M | $44.75 | Oct 22, 2024 |
| Avalon Ventures XI, L.P. | 10% Owner | EXERCISE | $100K–$500K | 12K | $18.07 | Oct 18, 2024 |
| Avalon Ventures XI, L.P. | 10% Owner | SELL | $1M+ | 1.7M | $46.30 | Oct 18, 2024 |
| Avalon Ventures XI, L.P. | 10% Owner | EXERCISE | $15K–$50K | 3K | $18.07 | Oct 1, 2024 |
| Avalon Ventures XI, L.P. | 10% Owner | SELL | $1M+ | 308K | $46.96 | Oct 1, 2024 |
| Meyer Andrew Hollman | Chief Business Off… | SELL | $1M+ | 50K | $45.96 | Sep 27, 2024 |
| Meyer Andrew Hollman | Chief Business Off… | EXERCISE | $100K–$500K | 50K | $4.21 | Sep 27, 2024 |
| DiRaimondo Thomas | Chief Scientific O… | SELL | $100K–$500K | 5K | $46.34 | Sep 27, 2024 |
| Campbell David Alan | President and CEO | SELL | $1M+ | 25K | $46.31 | Sep 27, 2024 |
| Lichter Jay | Director | SELL | $1M+ | 1.5M | $54.75 | Jun 5, 2024 |
| Reardon Tighe | CFO | SELL | $1M+ | 823K | $54.75 | Jun 5, 2024 |
| Avalon Ventures XI, L.P. | 10% Owner | SELL | $1M+ | 1.5M | $54.75 | Jun 5, 2024 |
| Reardon Tighe | CFO | BUY | $1M+ | 850K | $5.87 | Nov 15, 2023 |
| Lichter Jay | Director | BUY | $1M+ | 850K | $5.87 | Nov 15, 2023 |
| Avalon Ventures XI, L.P. | 10% Owner | BUY | $1M+ | 850K | $5.87 | Nov 14, 2023 |
| RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $1M+ | 495K | $12.46 | Jul 21, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 125 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11.2M | $1M+ | SH |
| STATE STREET CORP | 3.9M | $1M+ | SH |
| VANGUARD GROUP INC | 2.5M | $1M+ | SH |
| Prosight Management, LP | 2.4M | $1M+ | SH |
| ORBIMED ADVISORS LLC | 2.0M | $1M+ | SH |
| Alyeska Investment Group, L.P. | 1.3M | $1M+ | SH |
| Logos Global Management LP | 1.0M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 964K | $1M+ | SH |
| Point72 Asset Management, L.P. | 962K | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 886K | $1M+ | SH |
| Cormorant Asset Management, LP | 650K | $1M+ | SH |
| JANE STREET GROUP, LLC | 434K | $1M+ | SH |
| Squarepoint Ops LLC | 391K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 391K | $1M+ | SH |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 376K | $1M+ | SH |
| University of Wisconsin Foundation | 362K | $1M+ | SH |
| Walleye Capital LLC | 323K | $1M+ | SH |
| Pictet Asset Management Holding SA | 272K | $1M+ | SH |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 267K | $1M+ | SH |
| ADAR1 Capital Management, LLC | 245K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
8.9%
5.4M shares
SC 13G · Feb 9, 2026
6.4%
3.9M shares
SC 13G · Feb 6, 2026
5.2%
3.2M shares
SC 13G/A · Jan 8, 2026
5.8%
3.5M shares
SC 13G/A · Nov 7, 2025
10.0%
6.0M shares
Paradigm BioCapital Advisors LP
SC 13G/A · Aug 14, 2025
4.9%
2.9M shares
SC 13G/A · Aug 14, 2025
7.5%
4.5M shares
Adage Capital Management, L.P.
SC 13G/A · Aug 12, 2025
4.3%
2.5M shares
SC 13G · Jul 17, 2025
5.7%
3.3M shares
SC 13G/A · May 14, 2025
7.8%
4.6M shares
SC 13D/A · Mar 10, 2025
19.9%
12.0M shares
Paradigm BioCapital Advisors LP
SC 13G/A · Feb 14, 2025
6.0%
3.5M shares
SC 13G · Feb 14, 2025
6.1%
3.6M shares
Adage Capital Management, L.P.
SC 13G · Feb 12, 2025
5.3%
3.1M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Nov 14, 2024
0.0%
0 shares
SC 13G/A · Nov 14, 2024
1.9%
6 shares
SC 13G/A · Nov 14, 2024
4.8%
2.6M shares
SC 13G/A · Nov 12, 2024
15.0%
7.8M shares
SC 13D/A · Nov 8, 2024
1.8%
925K shares
SC 13G/A · Nov 4, 2024
300.0M shares
SC 13D/A · Oct 25, 2024
3.5%
1.8M shares
Janux Therapeutics, Inc. (Subject)
SC 13G · Oct 23, 2024
0.0%
0 shares
SC 13D/A · Oct 22, 2024
20.0%
10.4M shares
SC 13D/A · Oct 22, 2024
4.0%
2.1M shares
SC 13D/A · Sep 17, 2024
5.7%
3.0M shares
SC 13D/A · Sep 17, 2024
20.0%
10.7M shares
SC 13D/A · Aug 9, 2024
3.8%
2.0M shares
SC 13D/A · Jun 5, 2024
6.3%
3.3M shares
SC 13D/A · Mar 6, 2024
20.0%
10.6M shares
SC 13D/A · Mar 5, 2024
7.7%
3.9M shares
SC 13G/A · Feb 14, 2024
0.0%
0 shares
SC 13G/A · Feb 14, 2024
6.8%
6 shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2024
5.3%
2.4M shares
SC 13G/A · Feb 1, 2024
383.0M shares
Avalon Ventures XI, L.P. (“Avalon Ventures”)
SC 13D/A · Nov 15, 2023
9.5%
4.4M shares
SC 13G · Jul 10, 2023
4.9%
6 shares
Biotechnology Value Fund, L.P.
SC 13G · May 30, 2023
5.2%
2.2M shares
SC 13G/A · Feb 10, 2023
5.4%
2.4M shares
SC 13G · Jan 20, 2023
7.8%
3.3M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G · Feb 11, 2022
5.8%
2.4M shares
SC 13G · Feb 11, 2022
5.0%
2.3M shares
SC 13G · Jan 10, 2022
12.0%
5.0M shares